Answers are grounded in this paper and cite their sources.
Carbon monoxide (CO) is widely recognized as a poisonous gas due to its strong binding affinity for hemoglobin (Hb), which reduces oxygen-carrying capacity to a fatal degree at high concentrations. However, CO is also a critical gasotransmitter produced endogenously through heme degradation. At low concentrations, CO exerts immunomodulatory effects through the heme oxygenase-1 (HO-1) pathway, and exogenous administration has shown therapeutic benefit across multiple preclinical models, including cardiovascular disorders, shock, and acute kidney injury. Despite these promising effects, therapeutic CO delivery remains a major barrier to clinical translation, as inhalation poses inherent safety risks related to environmental exposure and precise dosing. Hemoglobin-based oxygen carriers (HBOCs) may offer a controlled method for CO delivery, with Hb functioning as a systemic reservoir capable of safely transporting CO. Because HBOCs directly interact with the microcirculation, understanding their effects on microvascular hemodynamics is essential for evaluating their safety and feasibility as CO-delivering therapeutics. As such, the objective of this study was to determine the effects of CO-saturated HBOCs on microvascular hemodynamics during a 10% hypervolemic infusion. To evaluate the microvascular effects of CO-saturation of a HBOC, Golden Syrian hamsters were instrumented with a dorsal skinfold window chamber and a catheter in the carotid artery. Animals received a hypervolemic infusion equal to 10% of the animal’s blood volume (top load), estimated as 7% of body weight. The test solutions were the same HBOC, saturated with CO or saturated with O 2 . Baseline measurements of mean arterial pressure (MAP), heart rate (HR), blood chemistry, and microhemodynamics were recorded before infusion, with follow-up measurements taken at 30-, 60-, and 90-minutes post-infusion. Microhemodynamic measurements included vessel diameter, flow, and functional capillary density. Regardless of test solution, systemic parameters remained comparable following infusion, with no noticeable deviations resulting from CO saturation. In the microcirculation, infusion of the CO-saturated HBOC maintained vessel diameter, flow, and functional capillary density to a similar degree as those observed with the O 2 -saturated HBOC. These findings indicate that CO-saturated HBOC preserves microvascular hemodynamics during hypervolemic infusion and performs comparably to a conventional O 2 -saturated HBOC. The maintenance of stable systemic and microvascular parameters supports the potential of polymerized Hb as a viable platform for controlled CO delivery. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
Martinez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: